Literature DB >> 20561285

ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players.

J R Ruiz1, M Fernández del Valle, Z Verde, I Díez-Vega, C Santiago, T Yvert, G Rodríguez-Romo, F Gómez-Gallego, J J Molina, A Lucia.   

Abstract

We examined the association of R577X polymorphism (rs1815739) in the α-actinin-3 (ACTN3) gene with "explosive" leg muscle power performance in a group of male and female elite volleyball players (n=66, 31 men, 35 women) and in a group of non-athletic male and female young adults (n=334, 243 men, 91 women). We assessed power performance by means of the vertical squat and counter-movement jump tests. We also determined whether the genotypic frequencies of the ACTN3 R577X genotypes differed between groups. We did not observe any effect of the ACTN3 R577X polymorphism on study phenotypes in both groups, regardless of gender (all P>0.05). Genotype frequencies were similar between volleyball and control groups (P=0.095). Moreover, we did not find an association between the ACTN3 R577X polymorphism and the likelihood of being an elite volleyball player using the dominant (RR vs RX+XX) and the recessive model (RR+RX vs XX). In summary, these findings suggest that the ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561285     DOI: 10.1111/j.1600-0838.2010.01134.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  13 in total

Review 1.  Advances in exercise, fitness, and performance genomics in 2010.

Authors:  James M Hagberg; Tuomo Rankinen; Ruth J F Loos; Louis Pérusse; Stephen M Roth; Bernd Wolfarth; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2011-05       Impact factor: 5.411

2.  ACTN3 genotype influences exercise-induced muscle damage during a marathon competition.

Authors:  Juan Del Coso; Marjorie Valero; Juan José Salinero; Beatriz Lara; Germán Díaz; César Gallo-Salazar; Diana Ruiz-Vicente; Francisco Areces; Carlos Puente; Juan Carlos Carril; Ramón Cacabelos
Journal:  Eur J Appl Physiol       Date:  2017-02-02       Impact factor: 3.078

3.  History-dependent force, angular velocity and muscular endurance in ACTN3 genotypes.

Authors:  Siacia Broos; Marc Van Leemputte; Louise Deldicque; Martine A Thomis
Journal:  Eur J Appl Physiol       Date:  2015-03-12       Impact factor: 3.078

Review 4.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

Review 5.  More than a 'speed gene': ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries.

Authors:  Juan Del Coso; Danielle Hiam; Peter Houweling; Laura M Pérez; Nir Eynon; Alejandro Lucía
Journal:  Eur J Appl Physiol       Date:  2018-10-16       Impact factor: 3.078

6.  ACTN3 X-allele carriers had greater levels of muscle damage during a half-ironman.

Authors:  Juan Del Coso; Juan José Salinero; Beatriz Lara; César Gallo-Salazar; Francisco Areces; Carlos Puente; David Herrero
Journal:  Eur J Appl Physiol       Date:  2016-12-02       Impact factor: 3.078

Review 7.  Genes for elite power and sprint performance: ACTN3 leads the way.

Authors:  Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

8.  The ACTN3 R577X variant in sprint and strength performance.

Authors:  Hyeoijin Kim; Keon-Hyoung Song; Chul-Hyun Kim
Journal:  J Exerc Nutrition Biochem       Date:  2014-12-06

9.  ACTN3 R577X polymorphism is not associated with team sport athletic status in Italians.

Authors:  Myosotis Massidda; Valeria Bachis; Laura Corrias; Francesco Piras; Marco Scorcu; Claudia Culigioni; Daniele Masala; Carla M Calò
Journal:  Sports Med Open       Date:  2015-03-27

10.  The ACTN3 R577X polymorphism across three groups of elite male European athletes.

Authors:  Nir Eynon; Jonatan R Ruiz; Pedro Femia; Vladimir P Pushkarev; Pawel Cieszczyk; Agnieszka Maciejewska-Karlowska; Marek Sawczuk; Dmitry A Dyatlov; Evgeny V Lekontsev; Leonid M Kulikov; Ruth Birk; David J Bishop; Alejandro Lucia
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.